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Abstract The p38 family of mitogen-activated protein kinases
is composed of several isoforms. Mxi2 is a splicing variant of
p38K that harbors a unique carboxy-terminus. Here we show that
this sole divergence results in remarkable differences between
Mxi2 and p38K. Mxi2 is distinctively activated by stress stimuli
and potently activated by mitogens. Mxi2 affinity for bona fide
p38 substrates is remarkably diminished and Mxi2 activity is
largely unaffected by the phosphatase CL100. Also, Mxi2
sensitivity to inhibition by SB203580 is greatly reduced.
Interestingly, we show that the p38 C-terminus is involved in
conferring sensitivity to this compound. Overall, our results point
to the p38 carboxy-terminus as a key determinant of the
biochemical properties of this family of kinases.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Mitogen-activated protein kinases (MAPKs) are cytoplas-
mic, proline-directed serine/threonine kinases that are acti-
vated in response to a wide array of extracellular stimuli,
including those that regulate cell proliferation, di¡erentiation,
development and in£ammation. MAPKs have been shown to
be pivotal elements in these cellular processes, acting as essen-
tial mediators in the transduction of signals from the cell sur-
face to the nucleus [1]. To date, four groups of mammalian
MAPKs have been studied in detail : extracellular signal-regu-
lated kinases (ERKs) [2], stress-activated protein kinases/c-Jun
N-terminal kinases (SAPKs/JNKs), p38 MAPKs [3,4] and the
ERK5/BMK1 MAPK [5]. The ERKs are potently activated
by growth factors. In contrast, SAPKs/JNKs and p38 are
mainly activated by cytokines and environmental stress,
although activation of various MAPK pathways by the
same stimuli often occurs [1,2].
p38K/RK/CSBP2 MAPK was ¢rst identi¢ed by virtue of its
homology to the yeast HOG MAPK and found to be acti-
vated by stress-inducing agents such as osmotic shock, heat
shock, UV radiation, lipopolysaccharide, protein synthesis in-
hibitors and in£ammatory cytokines such as IL-1 and TNF-K
[6^10]. Once activated, p38 can phosphorylate a number of
cytoplasmic proteins like MAPKAPK 2/3 [8,11] and cPLA2
[12]. And nuclear transcription factors including Ets family
proteins Elk-1 [13] and Sap-1a [14,15], ATF2 [10,13],
MEF2C [16] and CHOP10 [17].
A common feature to all MAPKs is the existence of several
isoforms in each family. With respect to the p38 family, in
addition to p38K/RK/CSBP2, isoforms p38L [18], p38Q/ERK6/
SAPK3 [19,20] and p38N/SAPK4 [21,22] have been described.
Moreover, splicing variants of p38K, namely CSBP1 [7] and
Mxi2 [23], and of p38L, termed p38L2 [24] and p38-2 [25],
have been reported, but the role of these molecules is still
largely unknown.
Mxi2 was isolated in a two-hybrid screen for proteins that
bind c-Myc partner protein Max. Mxi2 protein is identical to
p38 from amino acids 1 to 280 and harbors a unique C-ter-
minal 17 amino acid sequence. Its relative distribution in hu-
man tissues resembles closely that of p38 [23]. However, other
than its ability to bind and phosphorylate Max, that is also
shared by p38 [23], little is known about its regulation and
substrate a⁄nity that could help explain the role of an other-
wise almost identical protein to p38. The purpose of this study
was to examine Mxi2 biochemical properties, evaluating both
upstream and downstream events, which could provide us
with an insight into the importance of the C-terminus for
p38 MAPKs function. We have found that in spite of sharing
common characteristics with p38, Mxi2 activation is stimu-
lated by mitogens and di¡erentially activated by stress-induc-
ing stimuli. Mxi2 phosphorylating activity over bona ¢de p38
substrates as ATF2, Elk-1, Sap-1 and the MEF2 family is
remarkably low. Likewise, Mxi2 is incapable of stimulating
the transcriptional activity of the p38-responsive exchange
factor MEF2C. Moreover, Mxi2 sensitivity to dual-speci¢city
protein phosphatases capable of inactivating p38 is greatly
reduced. Also, Mxi2 sensitivity to the inhibitory properties
of pyridinyl imidazole drugs is remarkably lower than that
exhibited by p38. Interestingly, we show that the p38 C-ter-
minus can act as an additional determinant of the sensitivity
towards these inhibitors. Overall, our results highlight the
importance of the p38 carboxy-terminal portion for de¢ning
the biochemical properties of these kinases. Moreover, our
results are also indicative of Mxi2 having still unveiled regu-
latory and physiological functions distinct from those of p38.
2. Materials and methods
2.1. Materials
Hemagglutinin (HA) epitope-tagged p38K and Mxi2 [23] were sub-
cloned in pCDNA3. MKK6 was provided by Dr. R.J. Davis (Uni-
versity of Massachusetts). CL100 was from Dr. J.S. Gutkind (NIDR,
NIH). TNF-K was from Genzyme Corp., SB203580 and TPA were
from Calbiochem, anisomycin, sorbitol and cycloheximide were from
Sigma.
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2.2. Cell culture and transfection
Human 293T cells were regularly grown in DMEM^10% fetal calf
serum. Subcon£uent cells were transfected by the calcium phosphate
precipitation technique [26]. The total amount of plasmid DNA was
adjusted to 3^4 Wg per plate with vector DNA when necessary.
2.3. Kinase assays
Two days after transfection, cells were cultured overnight in serum-
free medium. Cells were then left untreated or stimulated with various
agents. Kinase assays were performed essentially as described [26] by
an in vitro immunocomplex assay in anti-HA immunoprecipitates
using myelin basic protein (MBP) (Sigma) as substrate.
2.4. Recombinant proteins
Glutathione S-transferase (GST) fusion proteins of the N-terminal
portion of ATF2 (1^109), c-Jun (1^93) [27], Elk-1 (310^428) and Sap-
1 (287^431) [15] and MEF2A, B and C [28] were puri¢ed by standard
procedures [15] and used as substrates as described above.
2.5. Immunoblotting
Total lysates were fractionated in SDS^PAGE gels and transferred
onto nitrocellulose ¢lters. Immunocomplexes were visualized by en-
hanced chemiluminescence detection (Amersham), using horseradish
peroxidase-conjugated secondary antibody (Cappel). Mouse monoclo-
nal anti-HA antibody was from Babco, mouse monoclonal anti-GST
antibody was from Santa Cruz. Anti-phospho-p38 and anti-p38 anti-
bodies were from New England Biolabs.
2.6. Reporter gene assays
Performed in NIH3T3 cells transfected using the calcium phosphate
precipitation technique with a L-galactosidase reporter vector, the
reporter plasmid pGE51-luc and vectors encoding either GAL4-
MEF2C fusion protein or GAL4 (1^147) [16]. The total amount of
DNA for each transfection was kept constant (5 Wg) using pCDNA3.
The luciferase activities were determined using a commercial kit
(Promega) following the manufacturer’s instructions and normalized
by dividing by the L-galactosidase activity.
3. Results
As a ¢rst approach to understand Mxi2 regulation, we in-
vestigated its activation kinetics. It is now well-established
that MAPKs stimulation is time-dependent, ERKs respond
to stimuli with an almost immediate peak of activity, while
SAPKs/JNKs and p38 MAPKs maximum activation occurs at
later stages [27,10]. Activation time course assays in 293T cells
transfected with HA epitope-tagged Mxi2 or p38K (referred to
as p38 hereafter) and stimulated with anisomycin revealed
that Mxi2 activity curve mirrors that of p38, reaching its
maximum after 10^15 min stimulation and decreasing there-
after (Fig. 1). However, Mxi2 phosphorylating activity, even
at the maximum levels, was almost 3-fold lower than that
exhibited by p38 for the same substrate, MBP, utilized in
this assay. Due to this, in subsequent experiments, ¢lm expo-
sition times for Mxi2 kinase assays were 3^4 times longer than
those for p38.
Fig. 1. Time-dependent activation of Mxi2. 293T cells transfected
with 1 Wg of constructs encoding HA-tagged Mxi2 and p38 were se-
rum-starved for 12 h and then stimulated with 10 Wg/ml anisomycin
for di¡erent times. At the indicated time points, the kinase activity
of immunoprecipitated Mxi2 and p38 was determined by an immu-
nocomplex in vitro kinase assay as described in Section 2, using
MBP as a substrate. The rate of phosphorylation was quanti¢ed by
phosphorimager analysis. Results represent the average þ S.E.M. of
three independent experiments.
Fig. 2. Mxi2 activation by diverse stimuli. (A) Serum-starved 293T cells previously transfected with HA-tagged Mxi2 and p38 were stimulated
for 20 min by heating at 42‡C in a water bath, or addition of: 100 nM TPA, 300 mM sorbitol, 60 mg/ml cycloheximide, 10 ng/ml TNF-K,
200 mM NaCl, 4 mM H2O2 and 10 Wg/ml anisomycin. Lower panels: expression levels of HA-Mxi2 and HA-p38 as determined in total lysates
by immunoblotting using an anti-HA mouse monoclonal antibody (Babco). Bottom: phospho-p38 and p38 levels detected in total lysates of
cells treated as indicated, determined by Western blotting using the corresponding antibodies. (B) Cells were stimulated by the addition of
10 WM LPA, 100 ng/ml EGF and 10 Wg/ml anisomycin for 20 min. Kinase activity of immunoprecipitated Mxi2 (open bars) and p38 (solid
bars) was determined by an immunocomplex in vitro kinase assay as described in Section 2, using MBP as a substrate. Data show the average
of three independent experiments.
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We next examined Mxi2 sensitivity to activation by external
agents. For this purpose, 293T cells were subjected to a panel
of stimuli that included: environmental stress stimuli as: heat,
osmotic shock induced by high concentrations of sorbitol and
NaCl, oxidative stress produced by H2O2, inhibitors of pro-
tein synthesis like cycloheximide and anisomycin; and TNF-
K, an in£ammatory cytokine. All of them well-known activa-
tors of the p38 family [1,10]. All the stimuli tested activated
Mxi2 to di¡erent extents, however, maximum activation was
induced by H2O2, while hyperosmolarity caused by sorbitol
and NaCl had minimal e¡ects on Mxi2 activation (Fig. 2A).
In sharp contrast to p38, which was potently activated by
osmotic shock and to a lesser extent by oxidative stress. Dif-
ferences in activation were not due to variations in the ex-
pression of Mxi2 and p38 proteins as demonstrated by anti-
HA Western blot analysis of the corresponding lysates (lower
panels). As an additional control, we assayed whether the
activation elicited on the transfected HA-tagged versions of
Mxi2 and p38 mimicked that one induced over the endoge-
nous proteins. For that purpose, we utilized an anti-phospho-
p38 antibody that speci¢cally recognizes activated p38. As
shown in Fig. 2A (lower panels), activation of the endogenous
p38, as determined by anti-phospho-p38 Western blotting,
resembled the one assayed on the transfected HA-p38. How-
ever, the anti-phosoho-p38 antibody utilized did not recognize
Mxi2. Neither the endogenous in the total lysates nor the HA-
tagged version in anti-HA immunoprecipitates (data not
shown). It is likely that conformational changes masking the
epitope account for this lack of reactivity in Mxi2.
In a similar fashion, we tested how Mxi2 reacted to stim-
ulation by mitogenic stimuli. Interestingly, we found that mi-
togens such as lysophosphatidic acid (LPA) and epidermal
growth factor (EGF) that barely a¡ected p38 catalytic activ-
ity, when compared to bona ¢de p38 stimulators as anisomy-
cin, markedly induced Mxi2 activation (Fig. 2B). Overall, the
observed di¡erences on the activation patterns of Mxi2 and
p38 by various stimuli suggest that these two isoforms may be
di¡erentially regulated.
We then compared the substrate speci¢city of Mxi2 and
p38. To do so, we immunopuri¢ed HA-tagged Mxi2 and
p38 from anisomycin-stimulated cells. The expression levels
of each construct were veri¢ed by anti-HA immunoblot
(data not shown) and equal amounts were utilized in an in
vitro kinase assay using bacterially produced ATF2 (1^109),
Jun (1^93), Elk-1 (310^428), Sap-1 (287^431), MEF2A,
MEF2B and MEF2C GST fusion proteins as substrates. As
shown in Fig. 3A, p38 strongly phosphorylated ATF2 and
Elk-1 and to a lesser extent Sap-1, MEF2A and MEF2C. In
contrast, Mxi2 activated to a level at which it e⁄ciently
phosphorylated the MAPK unspeci¢c substrate MBP, failed
to recognize Sap-1 and MEF2C as substrates. Likewise, the
degree of ATF2, Elk-1 and MEF2A phosphorylation by Mxi2
was also markedly diminished, about 7.5- and 4-fold, respec-
tively. Similar results were observed when H2O2 and sorbitol
were used as activators (data not shown).
As a parallel approach, we studied the response of a
MEF2C-dependent reporter, known to be activated by p38
[16], to stimulation by Mxi2. It was found that expression
of the upstream p38-speci¢c MAPKK MKK6 or p38 induced
a moderate increase on MEF2C-dependent luciferase activity
(Fig. 3B). But when co-expressed, these two proteins acted
synergistically to induce a potent MEF2C response. On the
other hand, Mxi2 failed to elicit any substantial increase on
MEF2C transcriptional activity, alone or in synergy with
MKK6. This lack of e¡ect was not due to Mxi2-reduced ex-
pression as veri¢ed by Western blotting (data not shown).
Fig. 3. Substrate speci¢city of Mxi2. In vitro kinase assays were performed with HA-tagged Mxi2 and p38 immunoprecipitated from transiently
transfected 293T cells stimulated with 10 Wg/ml anisomycin for 20 min. The kinase reactions were performed utilizing equal amounts (lower
panel) of MBP and bacterially produced GST-ATF2 (1^109), GST-Jun (1^93), GST-Elk-1 (310^428) and GST-Sap-1 (287^431), GST-MEF2A,
B and C as substrates. Substrate phosphorylation was quanti¢ed by phosphorimager analysis. (B) MEF2C-dependent gene expression was de-
termined in NIH3T3 cells cotransfected with a L-galactosidase reporter vector, the reporter plasmid pGE51-luc and an expression vector encod-
ing the GAL4-DNA binding domain fused to MEF2C transactivation domain, in addition to plasmids encoding MKK6, Mxi2 and p38 as acti-
vators. The luciferase activities were normalized by the L-galactosidase activity. Values are expressed relative to the luciferase activity detected
in vector-transfected cells. Results represent the average þ S.E.M. of three independent experiments.
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Together, these results, showing reduced a⁄nity and a low
catalytic activity exhibited by Mxi2 towards well-characterized
p38 substrates and e¡ectors, strongly argue in favor of Mxi2
and p38 having di¡erent biochemical roles.
A characteristic of most members of the p38 family is its
sensitivity to pyridinyl imidazoles that, in contrast, have no
inhibitory e¡ects on the activity of ERKs and JNKs [7].
Therefore, we proceeded to determine if the pyridinyl imida-
zole derivative SB203580 could e⁄ciently block the kinase
activity of Mxi2. As shown in Fig. 4, SB203580 could potently
block anisomycin-induced p38 activation in vivo with an IC50
of around 2 WM. In contrast, Mxi2 was much less sensible to
inhibition by this compound, showing an IC50 almost two
orders of magnitude higher, of around 100 WM.
p38 and Mxi2 di¡er solely in their respective 80 and 17 C-
terminal amino acids, but are identical in the ‘canonical’ re-
gion that confers sensitivity to pyridinyl imidazoles [29]. This
raised the possibility that the C-terminus of p38 MAPKs
might also determine to some extent the response to these
inhibitors. To check this hypothesis, we generated a p38 mu-
tant lacking its C-terminal 80 amino acids (p38vC) and as-
sayed its responsiveness to SB203580. It was found that the
catalytic activity of this protein was markedly reduced (3-fold)
with respect to the wild type (data not shown). On the other
hand, its sensitivity to SB203580 was greatly reduced, with an
IC50 that resembled that of Mxi2 (Fig. 4), suggesting that the
p38 carboxy-terminus may act as an additional determinant of
the sensitivity towards pyridinyl imidazole inhibitors.
Finally, in mammalian cells, inactivation of MAPKs can be
achieved by the action of dual-speci¢city MAPK phospha-
tases, which dephosphorylate the critical threonine and tyro-
sine residues in the activation loop of MAPKs [30]. Of these,
CL100/MKP-1 [31] has been shown to potently inhibit p38
activity [10]. Thus, we investigated the inhibitory e¡ects of
this phosphatase on Mxi2. Upon cotransfection with increas-
ing concentrations of a plasmid encoding CL100, it was found
that the phosphatase almost completely abolished p38 cata-
lytic activity induced by treatment with anisomycin. In con-
trast, CL100 e¡ects over anisomycin-induced Mxi2 activation
were far less dramatic with a barely 20% inhibition at its
maximum (Fig. 5). Identical results were obtained upon stim-
ulation with H2O2 and sorbitol (data not shown). This lack of
response of Mxi2 to pharmacological and biochemical inhibi-
tion further supports the idea that Mxi2 and p38 have distinct
regulation and biological functions, speci¢ed primarily by
their di¡erent carboxy-termini.
4. Discussion
The existence of multiple isoforms is a general characteristic
to all MAPKs [1]. Although the reason for this apparent re-
dundancy is not clearly understood, it could be speculated
that the presence of di¡erent isoforms provides the basis for
the generation of cell-speci¢c and stimulus-speci¢c responses
within a MAPK signaling cascade. In this study, we have
investigated the biochemical properties of Mxi2, a splicing
variant of p38K/CSBP2/RK [23] in comparison to those of
p38K, the best-studied member of the p38 family MAPKs.
We have found that Mxi2 is activated by stimuli such as
hyperosmolarity, environmental and oxidative stress, protein
inhibitors and in£ammatory cytokines to di¡erent extents,
being most sensitive to oxidative stress and least to osmotic
shock. Distinct responses to stimuli are a common feature to
most p38 isoforms. As such, p38L/L2 are only modestly sen-
sible to cytokines [18,24] and a reduced sensitivity towards
osmotic changes is also observed in p38N [21]. However, in
sharp contrast to most p38 family members, Mxi2 is potently
activated by mitogens as LPA and EGF. How Mxi2 unique
C-terminus accounts for this unprecedented behavior is pres-
ently not known. A previous study performed in COS cells
has found no increment on Mxi2 activity upon serum stimu-
lation, but in these cells Mxi2 exhibits an extremely high basal
activity, possibly due to cell-speci¢c variations, that may have
masked any stimulation [23].
Variations in substrate speci¢city are a common character-
istic among the members of the di¡erent MAPK families. As
such, JNK splicing isoforms exhibit a wide range of a⁄nities
towards JNK e¡ectors [32]. Likewise, p38 isoforms K, L and Q
Fig. 5. E¡ects of CL100 dual-speci¢city phosphatase on Mxi2 activ-
ity. 293T cells were transiently transfected with HA-tagged Mxi2 or
p38, with increasing concentrations (50 ng^1 Wg) of a vector encod-
ing the phosphatase CL100. Kinase activities were determined as de-
scribed in Section 2, using MBP as a substrate. Lower panels: ex-
pression levels of HA-Mxi2 and HA-p38 as determined in total
lysates by anti-HA immunoblotting.
Fig. 4. E¡ects of pyridinyl imidazole on Mxi2 activity. 293T cells
transiently transfected with HA-tagged Mxi2, p38 or p38vC were
serum-starved for 12 h and treated with increasing concentrations of
SB203580 for 30 min, prior to 20 min stimulation with 10 Wg/ml
anisomycin. After which kinase activities were determined as previ-
ously described in Section 2. Substrate phosphorylation was quanti-
¢ed by phosphorimager analysis. Results represent the average þ
S.E.M. of three independent experiments. Inset: protein expression
levels as determined by anti-HA immunoblot.
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also show di¡erences in their recognition of p38 family sub-
strates [18,19,21,22,24]. In the same fashion, the MEF2C tran-
scription factor is targeted di¡erentially by p38 isoforms [33].
Consequently, our results indicate that Mxi2 exhibits a re-
duced a⁄nity for p38 substrates like the transcription factors
ATF2, Elk-1, Sap-1, MEF2A and MEF2C. Accordingly,
Mxi2 is also incapable of stimulating MEF2C transcriptional
activity, further emphasizing Mxi2 di¡erential behavior.
Pyridinyl imidazole compounds are known to inhibit the
enzymatic activity of the p38 family proteins [7], and the var-
ious p38 isoforms show di¡erent sensitivities to these drugs.
As such, p38K, L, L2 and Q are potently inhibited at low
concentrations [18,24,19,22]. In contrast, p38N harboring a
T107M substitution that makes it insensible to pyridinyl imi-
dazoles [29] is largely una¡ected [21]. Conversely to its splic-
ing isoform p38K, Mxi2 exhibits only a modest susceptibility
to inhibition by SB203580. The fact that Mxi2 and p38 are
100% homologous in the region to which pyridinyl imidazoles
bind, the ATP binding pocket [34], implies that some degree
of sensitivity to this compounds could be conferred by some
motif C-terminal to residue 280, in which Mxi2 and p38 di-
verge completely. Indeed, we show that a p38 mutant lacking
its C-terminal 80 amino acids exhibits a markedly reduced
sensitivity to SB203580. These variations on the behavior of
p38 isoforms to inhibition by pyridinyl imidazole compounds
should be taken into account when interpreting the e¡ects of
such inhibitors on potential p38 functions.
Our results also demonstrate that Mxi2 activation is largely
una¡ected by the over-expression of the dual-speci¢city pro-
tein phosphatase CL100/MKP-1 [31], as opposed to p38 that
is e⁄ciently inactivated by the phosphatase. It is noteworthy
that the sevenmaker mutation (D319N) in ERK2 makes it
resistant to inactivation by dual-speci¢city phosphatases as
MPK-3 [35,36], probably due to the loss of its ability to
bind the phosphatases [36]. In this respect, the relevance of
our ¢ndings is bolstered by the recent description of the ‘CD
domain’ [37], a conserved docking motif in MAPKs that
serves as a common site for binding to substrates, activators
and dual-speci¢city protein phosphatases. The highly con-
served residue homologous to ERK2 D319 maps within this
motif. In the case of p38K, the CD domain is located at
residues 308^321, included in the 80 C-terminal amino acids
that are absent from Mxi2. This strongly suggests that the
reduced a⁄nity that Mxi exhibits towards well-established
p38 substrates and p38-interacting phosphatases is due to
the absence of a docking motif to which p38-interacting pro-
teins could e¡ectively bind. The CD domain contains an
acidic cluster crucial for e⁄ciently interacting with a region
of basic amino acids present in MAPK-docking sites [37].
Mxi2 lacks the ‘high a⁄nity’ -DPDD- acidic cluster found
in p38. However, Mxi2 unique C-terminus harbors a nega-
tively charged -DIE- cluster. Whether this sequence could
represent a ‘low a⁄nity’ docking motif is presently under
study.
Overall, we conclude that Mxi2 particular carboxy-terminus
confers unique characteristics to this protein. Di¡erential re-
sponses to external stimuli, in particular to mitogens, its low
speci¢city for known p38 substrates and its reduced respon-
siveness to inhibitors such as pyridinyl imidazoles and dual-
speci¢city phosphatases, clearly point to Mxi2 as an atypical
member of the p38 MAPKs, with yet to be unveiled, distinc-
tive, biochemical roles, that in addition to its regulatory char-
acteristics are under current investigation.
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